Animal Vaccines Market

  • Published on 2025-11-06
  • Report Code: 1107
  • 170-350 pages
Animal Vaccines Market

Animal Vaccines Market: By Type (Companion Animal, Livestock Animal, Aquaculture and Others): By Product (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines): Global Analysis by Market size, share & trends for 2020-2021 and forecasts to 2031

Table Of Content

Contents          

  1. Executive Summary
  2. Animal Vaccines Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Animal Vaccines Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Animal Vaccines Market  
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Animal Vaccines Market: Market Segmentation
    1. By Regions: Market Share (2020-2030F)
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Type: Market Share (2020-2030F)
      1. Companion Animal, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Livestock Animal, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Aquaculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Product: Market Share (2020-2030F)
      1. Attenuated Vaccines, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Inactivated Vaccines, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Subunit Vaccines, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  1. Company Profile          
    1.  Zoetis (US)
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Merck Animal Health (US)
    3. Boehringer Ingelheim (Germany)
    4. Elanco (US)
    5. Ceva (US)
    6. Virbac (France)
    7. Vetoquinol (France)
    8. Phibro Animal Health (US)
    9. Hester Biosciences (India)
    10. HIPRA (Spain)
    11. Biogenesis Bago (Argentina)
    12. Other Prominent Players

Consultant Recommendation

The above given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients